Immunomodulatory drugs in the management of SARS-CoV-2

DR Burrage, S Koushesh, N Sofat - Frontiers in immunology, 2020 - frontiersin.org
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?

C Marasca, A Ruggiero, M Napolitano, G Fabbrocini… - Medical …, 2020 - Elsevier
The emergence of the novel beta Coronavirus has raised serious concerns due to the virus
rapid dissemination worldwide. Many areas throughout the world are now experiencing the …

Impact of COVID-19 pandemic on dermatologists and dermatology practice

YJ Bhat, A Aslam, I Hassan… - Indian Dermatology Online …, 2020 - journals.lww.com
The COVID-19 pandemic has directly or indirectly affected every human being on this
planet. It's impact on the healthcare system has been devastating. The medical fraternity …

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …

Targeting cytokine storm to manage patients with COVID-19: a mini-review

N Roshanravan, F Seif, A Ostadrahimi… - Archives of medical …, 2020 - Elsevier
Corona Virus Disease 2019 (COVID-19) pandemic is rapidly spreading all over the world.
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …

Dermatological manifestations associated with COVID-19 infection

M Panda, S Dash, B Behera, A Sil - Indian journal of dermatology, 2021 - journals.lww.com
The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) causing the 2019
coronavirus disease (COVID-19) has infected millions in recent years and is a major public …

Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …

[HTML][HTML] Management of psoriasis during the coronavirus disease 2019 pandemic

KJ Tan, MRN Encarnacion, O Marushchak… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) was first reported in late December 2019
and, since then, has rapidly taken over the globe, with the scientific world furiously working …

COVID‐19 and exacerbation of dermatological diseases: a review of the available literature

K Aram, A Patil, M Goldust, F Rajabi - Dermatologic Therapy, 2021 - Wiley Online Library
Since the emergence of the new coronavirus disease 19 (COVID‐19) pandemic, there has
been a concern for the patients with chronic autoimmune diseases including dermatological …

The understanding of the immunopathology in COVID-19 infection

D Tascioglu, E Akkaya, S Genc - Scandinavian journal of clinical …, 2021 - Taylor & Francis
Coronaviruses belonging to the Coronaviridae family are single-stranded RNA viruses. The
entry of SARS-CoV-2 is accomplished via ACE-2 receptors. SARS-CoV-2 infection …